Professor Chris Evans discusses EDX Medical’s growth ambitions in new London South East interview
Professor Sir Chris Evans, Founder and Chief Scientific Officer of EDX Medical, has taken part…
Founder & CSO Sir Chris Evans interviewed by DirectorsTalks Interviews
Cancer diagnostics are moving beyond broad screening and into precision-led detection, and EDX Medical founder…
EDX MEDICAL at forefront of new Scottish Prostate Cancer Initiative
EDX is to be the primary delivery partner in the Scottish Prostate Cancer Initiative, a…
New Advanced Bowel Cancer Testing Service
EDX Medical is pleased to announce the launch of a new, highly accurate testing service,…
New Advanced Testicular Cancer Testing Launched in UK
The most advanced testing service for testicular cancer ever available has been launched in the…
EDX Medical Responds to New Report Highlighting Urgent Need for Faster, Broader Cancer Biomarker Testing in the UK
The recent joint report from Macmillan Cancer Support and AstraZeneca, published in Future Oncology has…
Partnership with NHS to provide advanced pneumonia test
EDX Medical Group is to complete the development of a new pneumonia test for critically…
EDX Medical host exclusive Curesponse webinar
EDX Medical was proud to host an exclusive webinar: Curesponse – Personal Oncology: cResponse™ in Practice,…
EDX Medical to work with Spire Healthcare Group on advancing major disease diagnostics
EDX Medical is delighted to announce that it has signed an agreement with Spire Healthcare…
Professor Sir Chris Evans Discusses Groundbreaking Prostate Cancer Test on The Naked Scientists Podcast
Professor Sir Chris Evans recently appeared on The Naked Scientists podcast ‘Prostate Cancer: When Should…
